Company / Profit Margin
INOVIO PHARMACEUTICALS, INC. Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-49254.3%
FY2025
5-year range
-49254.3% / -2245.4%
FY2021-FY2025
Trend
-203.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin changed -203% YoY in FY2025, a notable deviation from the 9-year average annual change of -201%.
Based on SEC 10-K filings.
-49254.3% in FY2025 with a 5-year CAGR of -48936.2%.
Declined from -17109.9% to -49254.3% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -47008.9pp
- 5-Year Change
- -48936.2pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin decreased 203.3% year-over-year.
- Peak profit margin was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -49254.3% | -203.3% |
| FY2024 | -16239.9% | +5.1% |
| FY2023 | -17109.9% | -662.0% |
| FY2022 | -2245.4% | +22.6% |
| FY2021 | -2902.8% | -812.5% |
| FY2020 | -318.1% | -52.3% |
| FY2019 | -208.9% | -0.2% |
| FY2018 | -208.5% | -189.8% |
| FY2017 | -71.9% | +79.2% |
| FY2016 | -345.4% | +29.5% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026